RPRX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.
Repros Therapeutics Inc's cash flow for capital expenditures for the three months ended in Mar. 2014 was $-0.29 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2014 was $-0.90 Mil.
Repros Therapeutics Inc Cash Flow for Capital Expenditures for the trailing twelve months (TTM) ended in Mar. 2014 was -0.231 (Jun. 2013 ) + -0.308 (Sep. 2013 ) + -0.072 (Dec. 2013 ) + -0.285 (Mar. 2014 ) = $-0.90 Mil.
Repros Therapeutics Inc Annual Data
Repros Therapeutics Inc Quarterly Data